MULLENNIX STEPHEN (COO) sold 7.3% of their position (608.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $15.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/18/2019ACC: 0001209191-19-056923
-608.00
Net shares
Net seller
$15.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.76K acquired · 2.37K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.76K
Price / share
—
Trade value
—
% of position
26.9%
11/14/2019
6.53K→8.29K
Ordinary Shares
Direct
Shares
−608.00
Price / share
$26.00
Trade value
$15.81K
% of position
7.3%
11/14/2019
8.29K→7.68K
Total
Net shares
+1.15K
Net value
-$15.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/14/2019 | M · Option Exercise | +1.76K | — | — | 26.9% | 6.53K | 8.29K |
| Ordinary Shares Direct | 11/14/2019 | S · Sale | −608.00 | $26.00 | $15.81K | 7.3% | 8.29K | 7.68K |
| Total | +1.15K | -$15.81K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.76K shares
Shares
−1.76K
Strike price
Held after
8.80K
Exercisable
—
11/14/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.76K shares | 11/14/2019 | M · Option Exercise | −1.76K | — | 8.80K |